PAICA: A Method for Characterizing Platelet-Associated Antibodies - Its Application to the Study of Idiopathic Thrombocytopenic Purpura and to the Detection of Platelet-bound c7E3

Summary

In idiopathic thrombocytopenic purpura (ITP), autoantibodies reacting with antigens on the platelet membrane bring about accelerated platelet destruction. We now report PAICA (“Platelet-Associated IgG Characterization Assay”), a method for detecting autoantibodies bound to specific membrane glycoproteins in total platelet lysates. This monoclonal antibody (MAb) capture assay takes into account the fact that antibodies on circulating platelets may be translocated to internal pools as well as being on the surface. A total of twenty ITP patients were examined by PAICA, and the results compared with those obtained by measuring (i) serum antibodies bound to paraformaldehyde-fixed control platelets by ELISA, (ii) IgG bound to the surface of the patient’s own platelets by flow cytometry (PSIgG), (iii) total platelet-associated IgG (PAIgG) by ELISA and (iv) serum antibodies reacting with control platelets by MAIPA (“Monoclonal Antibody-specific Immobilization of Platelet Antigens”). Of twelve patients with elevated PAIgG, nine had increased PSIgG yet eleven reacted positively in PAICA. Of these, eight possessed antibodies directed against GP Ilb-IIIa, two against GP Ib-IX and one patient possessed antibodies directed against GP Ilb-IIIa and GP Ia-IIa respectively. Only seven of the patients possessed serum antibodies detectable by MAIPA. PAICA was also able to detect platelet-associated c7E3 (the chimeric form of Fab fragments of the MAb 7E3) following its infusion during antithrombotic therapy, when it proved more sensitive over a seven-day period than a MAIPA assay adapted for assessing surface-bound antibody. We propose that PAICA provides added sensitivity to the detection of platelet-associated antibodies in immune thrombocytopenias or following therapy with humanized MAbs.

• References

• 1 Dixon R, Rosse W, Ebbert L. Quantitative determination of antibodies in idiopathic thrombocytopenic purpura: Correlation of serum and platelet-bound antibody with clinical response. N Engl J Med 1975; 292: 230-236
• 2 Kelton JG. The serological investigation of patients with autoimmune thrombocytopenia. Thromb Haemost 1995; 74: 228-233
• 3 McMillan R. Clinical role of antiplatelet antibody assays. Sem Thromb Haemost 1995; 21: 37-45
• 4 Lin RY, Levin M, Nygren EN, Norman A, Lorenzana FG. Assessment of platelet antibody by flow cytometric and ELISA technique: A comparison study. J Lab Clin Med 1990; 116: 479-486
• 5 von dem Bome AEGKr, Verheugt WA, Oosterhof F, Von Riesz E, Brutel de la Riviere A, Engelfriet CP. A simple immunofluorescence test for the detection of platelet antibodies. Br J Haematol 1978; 39: 195-206
• 6 von dem Bome AEG, Helmerhorst FM, van Leeuwen EF, Pegels HG, von Riesz E, Engelfriet CP. Autoimmune thrombocytopenia: detection of platelet autoantibodies with the suspension immunofluorescence test. Br J Haematol 1980; 45: 319-327
• 7 Christopoulos CG, Kelsey HC, Machin SJ. A flow-cytometric approach to quantitative estimation of platelet surface immunoglobulin G. Vox Sang 1993; 64: 106-115
• 8 Latorraca A, Lanza F, Moretti S, Ferrari L, Reverberi R, Galluccio L, Castaldi G. Flow cytometric analysis of anti-platelet antibodies in idiopathic thrombocytopenic purpura. Haematologica 1994; 79: 269-272
• 9 Kiefel V, Santoso S, Weisheit M, Mueller-Eckardt C. Monoclonal antibody-specific immobilization of platelet antigens (MAIPA): a new tool for the identification of platelet reactive antibodies. Blood 1987; 70: 1722-1726
• 10 Kiefel V, Santoso S, Mueller-Eckardt C. Serological, biochemical and molecular aspect of platelet autoantigens. Semin Hematol 1992; 29: 26-33
• 11 Furihata K, Nugent DJ, Bissonette A, Aster RH, Kunicki TJ. On the association of platelet-specific alloantigen, Pen³, with glycoprotein Ilia: Evidence for the heterogeneity of glycoprotein Ilia. J Clin Invest 1987; 80: 1624-1630
• 12 McMillan R, Tani P, Millard F, Berchtold P, Renshaw L, Woods VL. Platelet-associated and plasma anti-glycoprotein autoantibodies in chronic ITP. Blood 1987; 70: 1040-1045
• 13 Tomiyama Y, Take H, Honda S, Furubayashi T, Mizutani H, Tsubakio T, Kurata Y, Yonezawa T, Tarui S. Demonstration of platelet antigens that bind platelet-associated autoantibodies in chronic ITP by direct immuno-precipitation procedure. Br J Haematol 1990; 75: 92-8
• 14 Beardsley D, Spiegel J, Jacobs M, Handin R, Lux S. Platelet membrane glycoprotein Ilia contains target antigens that bind anti-platelet antibodies in immune thrombocytopenias. J Clin Invest 1984; 73: 1701-1707
• 15 Woods VL, Oh EH, Mason D, McMillan R. Autoantibodies against the platelet glycoprotein Ilb/IIIa complex in patients with chronic ITP. Blood 1984; 63: 368-75
• 16 Fujisawa K, Tani P, O’Toole TE, Ginsberg MH, McMillan R. Different specificities of platelet-associated and plasma autoantibodies to platelet GP Ilb-IIIa in patients with chronic immune thrombocytopenic purpura. Blood 1992; 79: 1441-6
• 17 Kiefel V, Santoso S, Kaufmann E, Mueller-Eckhardt C. Autoantibodies against platelet glycoprotein MX: a frequent finding in autoimmune thrombocytopenic purpura. Br J Haematol 1991; 79: 256-262
• 18 Woods VL, Kurata Y, Montgomery RR, Tani O, Mason D, Oh EH, McMillan R. Autoantibodies against platelet glycoprotein lb in patients with chronic immune thrombocytopenic purpura. Blood 1984; 64: 156-160
• 19 Deckmyn H, Chew SL, Vermylen J. Lack of platelet response to collagen associated with an autoantibody against GP la: A novel cause of acquired qualitative platelet dysfunction. Thromb Haemost 1990; 64: 74-9
• 20 George JN. Platelet immunoglobulin G: its significance for the evaluation of thrombocytopenia and for understanding the origin of α-granule proteins. Blood 1990; 76: 859-870
• 21 Kelton JG, Powers PJ, Carter CJ. A prospective study of the usefulness of the. measurement of platelet-associated IgG for the diagnosis of idiopathic thrombocytopenic purpura. Blood 1982; 60: 1050-1053
• 22 Handagama PJ, George JN, Shuman MA, McEver RP, Bainton DF. Incorporation of a circulating protein into megakaryocyte and platelet granules. Proc Natl Acad Sci USA 1987; 84: 861-865
• 23 Topol EJ, Califf RM, Weisman HF, Ellis SG, Tcheng JE, Worley S, Ivanhoe R, George BS, Fintel D, Weston M, Sigmon K, Anderson KM, Lee KL. Willerson JT on behalf of the EPICS investigators. Randomised trial of coronary intervention with antibody against platelet Ilb/IIIa integrin for reduction of clinical restenosis: results at six months. Lancet 1994; 343: 881-6
• 24 Coller BS. A new murine monoclonal antibody reports an activation-dependent change in the conformation and/or microenvironment of the platelet glycoprotein Ilb/IIIa complex. J Clin Invest 1985; 76: 101-108
• 25 Coller BS, Scudder LE. Inhibition of dog platelet function by in vivo infusion of F(ab’)₂fragment of a monoclonal antibody to the platelet glycopro-tein Ilb-IIIa receptor. Blood 1985; 66: 1456-1459
• 26 Hourdille P, Heilmann E, Combrie R, Winckler J, Clemetson K, Nurden AT. Thrombin induces a rapid redistribution of GP Ib-IX complexes within the membrane systems of activated human platelets. Blood 1990; 76: 1503-1513
• 27 Jallu V, Diaz-Ricart M, Ordinas A, Pico M, Vezon G, Nurden AT. Two human antibodies reacting with different epitopes on integrin beta-3 of platelets and endothelial cells. Eur J Biochem 1994; 222: 743-51
• 28 Pidard D, Montgomery RR, Bennett JS, Kunicki TJ. Interaction of AP-2, a monoclonal antibody specific for the human glycoprotein Ilb-IIIa complex, with intact platelets. J Biol Chem 1983; 258: 12582-12586
• 29 Bihour C, Durrieu-Jais C, Besse P, Nurden P, Nurden AT. Flow cytometry reveals activated GP Ilb-IIIa complexes on platelets from patients undergoing thrombolytic therapy after acute myocardial infarction. Blood Coag Fibrinolysis 1995; 6: 395-410
• 30 Clofent-Sanchez G, Laroche-Traineau J, Bermudes H, Lucas S, Nurden P, Nurden A. A patient with autoimmune thrombocytopenic purpura demonstrating serum antibodies reactive with mouse cross-reactive idiotypes. Clin Immunol Immunopath 1995; 77: 271-281
• 31 Clofent-Sanchez G, Lucas S, Laroche-Traineau J, Rispal P, Pellegrin JL, Nurden P, Nurden A. Autoantibodies and anti-mouse antibodies in thrombocytopenic patients as assessed by different MAIPA assays. Br J Haematol, in press
• 32 Kiefel V. The MAIPA assay and its applications in immunohaematology. Transfusion Med 1992; 2: 181-188
• 33 Tcheng JE, Ellis SG, George BS, Kereiakes DJ, Kleiman NS, Talley JD, Wang AL, Weisman HJ, Califf RM, Topol EJ. Pharmacodynamics of chimeric glycoprotein Ilb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 1994; 90: 1757-1764
• 34 Shulman NR, Reid DM. Platelet immunology. In: Hemostasis and Thrombosis. Basic Principles and Clinical Practice Colman RW, Hirsh J, Marder VJ, Salzman EW. eds Philadelphia: JB Lippincott: 1994: 414-468
• 35 Santoso S, Zimmermann U, Neppert J, Mueller-Eckhardt C. Receptor patching and capping of platelet membranes induced by monoclonal antibodies. Blood 1986; 67: 343-349
• 36 Morgenstern E, Ruf A, Patscheke H. Transport of anti-glycoprotein Ilb/IIIa-antibodies into the alpha granules of unstimulated human blood platelets. Thromb Haemost 1992; 67: 121-125
• 37 Nomura S, Yanabu M, Fukuroi T, Kido H, Kawakatsu T, Yamaguchi K, Suzuki M, Kokawa T, Yasunaga K. Anti-glycoprotein Ilb/IIIa autoantibodies are reversibly internalized into platelets in idiopathic (autoimmune) thrombocytopenic purpura. Autoimmunity 1992; 13: 133-140
• 38 Hamamoto K, Nomura S, Suzuki M, Ohga S, Fukuhara S. Internalization of an anti-glycoprotein Ilb/IIIa by HEL cells. Throm Haemost 1995; 73: 291-296
• 39 Christopoulos C. Platelet surface IgG in patients receiving infusions of Fab fragments of a chimaeric monoclonal antibody to glycoprotein Ilb-IIIa. Clin Exp Immunol 1994; 98: 6-11
• 40 Kiefel V, Freitag E, Kroll H, Santoso S, Mueller-Eckhardt C. Platelet autoantibodies (IgG, IgM, IgA) against glycoproteins Ilb/IIIa and MX in patients with thrombocytopenia. Ann Hematol 1996; 72: 280-285